Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Using larynx and vocal tract techniques to lower vocal fold contact pressure

Official title: Laryngeal and Vocal Tract Strategies to Reduce Vocal Fold Contact Pressure

Run by University of California, Los Angeles · NCT06165536 · Data updated 2026-11-12

This program will try resonant voice therapy to see if it lowers vocal fold contact pressure in adults with phonotraumatic mid-membranous vocal fold lesions.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedJanuary 31, 2028
Study endsJanuary 31, 2028
Registry record updatedDecember 15, 2025
Trial IDNCT06165536 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–40 with bilateral mid-membranous lesions judged phonotraumatic by a fellowship-trained laryngologist who have been referred for resonant voice therapy and can complete CT scans and in-vivo phonation measurements.

Probably not a fit

Patients with vocal fold lesions unlikely to respond to voice therapy (e.g., cysts), significant medical comorbidities beyond seasonal allergy or reflux, claustrophobia, or who cannot reproduce required pitches/intensities are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will have adults (ages 18–40) with clinician-diagnosed phonotraumatic mid-membranous vocal fold lesions receive a standardized resonant voice therapy program. They will measure vocal fold contact pressure directly in vivo and use CT scans to compare laryngeal and vocal tract configurations before and after initial voice training. The team will relate immediate physical changes to perceptual, acoustic, and subglottic pressure measures and track patient-reported outcomes across longer-term therapy. Findings will test whether the physical adjustments predicted by prior simulations occur in people and whether early pressure reductions predict better therapy results.

Why it matters

Potential benefit: If successful, this could help clinicians target voice therapy more precisely to reduce injurious contact pressure and improve long-term voice outcomes.

How similar studies have gone: This approach is novel for in vivo human measurement—prior simulation and laboratory modeling suggested favorable adjustments, but direct confirmation in people has not been done.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 18-40 years (to minimize developmental changes associated with adolescent and elderly age)
* Clinic diagnosis by a fellowship trained laryngologist of mid-membranous lesions that by history and appearance are phonotraumatic
* Must be referred for voice therapy

Exclusion Criteria:

* Medical comorbidities (e.g., autoimmune disorders) beyond seasonal allergy and laryngopharyngeal reflux
* Vocal fold lesions generally regarded to be less responsive to voice therapy (e.g. vocal fold cysts).
* Claustrophobia
* Inability to replicate fundamental frequencies required for the study at the intensity levels determined

Where it's running

  • UCLA Rehab Center
    Los Angeles, California, United States
    Recruiting

Study contacts

  • Principal investigator: Zhaoyan Zhang — University of California, Los Angeles
  • Study coordinator: Zhaoyan Zhang
  • Email: zyzhang@ucla.edu
  • Phone: 3102064324

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.